WHO subvariants of indolent mastocytosis: Clinical details and prognostic evaluation in 159 consecutive adults

Blood

Volumn 115, Issue 1, 2010, Pages 150-151

  Pardanani, Animesh ^a   Lim, Ken Hong ^a,b   Lasho, Terra L ^a   Finke, Christy M ^a   McClure, Rebecca F ^a   Li, Chin Yang ^a   Tefferi, Ayalew ^a  

^a MAYO CLINIC   (United States)

^b MACKAY MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MARROW DISEASE; GENE MUTATION; HUMAN; INCIDENCE; KARYOTYPE; LETTER; MASTOCYTOSIS; PRIORITY JOURNAL; SURVIVAL; WORLD HEALTH ORGANIZATION; ADULT; AGED; CLASSIFICATION; DEMOGRAPHY; FEMALE; LIFE EXPECTANCY; MALE; MIDDLE AGED; PATHOLOGY; PROGNOSIS; SYSTEMIC MASTOCYTOSIS;

ADULT; AGED; AGED, 80 AND OVER; DEMOGRAPHY; FEMALE; HUMANS; LIFE EXPECTANCY; MALE; MASTOCYTOSIS, SYSTEMIC; MIDDLE AGED; PROGNOSIS; WORLD HEALTH ORGANIZATION; YOUNG ADULT;

EID: 74949103091     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-10-249979     Document Type: Letter

References (3)

1. Horny HP, Metcalfe DD, Bennett JM, et al. Mastocytosis. In: Swerdlow SH, Campo E, Harris NL, et al, eds. WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues. 4th ed. Lyon, France: International Agency for Research and Cancer (IARC);2008:54-63.
2. Lim KH, Tefferi A, Lasho TL, et al. Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors. Blood. 2009;113(23):5727-5736.
3. Kittur J, Knudson RA, Lasho TL, et al. Clinical correlates of JAK2V617F allele burden in essential thrombocythemia. Cancer. 2007;109(11):2279-2284.